Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019296957> ?p ?o ?g. }
- W2019296957 endingPage "1114" @default.
- W2019296957 startingPage "1104" @default.
- W2019296957 abstract "Study Objectives. To evaluate trends in adverse symptoms as blood pressure becomes controlled, and to determine if these symptoms are influenced by social support and self-efficacy. Design. Secondary analysis from a randomized controlled study of physician-pharmacist collaboration to improve blood pressure control. Setting. Five university-affiliated primary care clinics. Patients. A total of 179 patients (aged 21–85 yrs) with uncontrolled primary hypertension who were taking no antihypertensive drugs or up to three antihypertensive drugs at baseline were randomized to the intervention group, in which pharmacists were involved in their care, or to the control group, who received usual care from their physicians. Of these patients, 160 completed the study: 92 were in the intervention group, and 68 were in the control group. Intervention. In both groups, patient-reported symptoms suggestive of adverse drug reactions (ADRs) were recorded at each study visit with use of a structured ADR questionnaire. Social support and self-efficacy questionnaires were also administered at each study visit. Measurements and Main Results. Patients' ADR scores decreased significantly from baseline to the end of the study in both the control (from a mean of 26.5 to 18.4) and intervention (from 29.9 to 22.7) groups (p<0.0001 for both comparisons), although no significant difference was noted between groups. The mean ± SD number of antihypertensive drugs/patient increased in both the intervention (from 1.5 ± 1.0 to 2.4 ± 0.9 drugs) and control (from 1.4 ± 1.0 to 1.9 ± 1.0 drugs) groups; however, the difference between groups was significant only at the end of the study. Additional analyses were performed on self-efficacy and social support to determine a potential reason for the reduction in ADR scores despite an increase in drug use. Improvements in self-efficacy and social support scores were significantly and independently associated with improvement in ADR score (p<0.05). Conclusions. In both groups, ADR scores improved despite an increase in antihypertensive drug use. Improvements in social support and, to a lesser extent, self-efficacy were associated with improvements in ADR scores. Patients should not expect an increase in distressful symptoms as their blood pressure becomes controlled with antihypertensive drugs, especially when adequate social support is available." @default.
- W2019296957 created "2016-06-24" @default.
- W2019296957 creator A5016334678 @default.
- W2019296957 creator A5031308973 @default.
- W2019296957 creator A5035229665 @default.
- W2019296957 creator A5042906478 @default.
- W2019296957 creator A5076440455 @default.
- W2019296957 date "2008-09-01" @default.
- W2019296957 modified "2023-09-27" @default.
- W2019296957 title "Reduction in Adverse Symptoms as Blood Pressure Becomes Controlled" @default.
- W2019296957 cites W1980274304 @default.
- W2019296957 cites W1997584320 @default.
- W2019296957 cites W1998446342 @default.
- W2019296957 cites W2005191333 @default.
- W2019296957 cites W2010961718 @default.
- W2019296957 cites W2021458034 @default.
- W2019296957 cites W2029771114 @default.
- W2019296957 cites W2040445085 @default.
- W2019296957 cites W2053866035 @default.
- W2019296957 cites W2075476524 @default.
- W2019296957 cites W2082029312 @default.
- W2019296957 cites W2084862572 @default.
- W2019296957 cites W2089879328 @default.
- W2019296957 cites W2098100212 @default.
- W2019296957 cites W2099017761 @default.
- W2019296957 cites W2100019263 @default.
- W2019296957 cites W2106173816 @default.
- W2019296957 cites W2110162631 @default.
- W2019296957 cites W2112908199 @default.
- W2019296957 cites W2120235169 @default.
- W2019296957 cites W2129514898 @default.
- W2019296957 cites W2138461535 @default.
- W2019296957 cites W2143072217 @default.
- W2019296957 cites W2156121263 @default.
- W2019296957 cites W2160801689 @default.
- W2019296957 cites W2163828728 @default.
- W2019296957 cites W2164579243 @default.
- W2019296957 cites W2172032309 @default.
- W2019296957 cites W2318174853 @default.
- W2019296957 cites W2562329777 @default.
- W2019296957 cites W4236421691 @default.
- W2019296957 cites W4236922299 @default.
- W2019296957 cites W4254495812 @default.
- W2019296957 cites W4376848291 @default.
- W2019296957 doi "https://doi.org/10.1592/phco.28.9.1104" @default.
- W2019296957 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2768032" @default.
- W2019296957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18752381" @default.
- W2019296957 hasPublicationYear "2008" @default.
- W2019296957 type Work @default.
- W2019296957 sameAs 2019296957 @default.
- W2019296957 citedByCount "12" @default.
- W2019296957 countsByYear W20192969572012 @default.
- W2019296957 countsByYear W20192969572013 @default.
- W2019296957 countsByYear W20192969572016 @default.
- W2019296957 countsByYear W20192969572021 @default.
- W2019296957 crossrefType "journal-article" @default.
- W2019296957 hasAuthorship W2019296957A5016334678 @default.
- W2019296957 hasAuthorship W2019296957A5031308973 @default.
- W2019296957 hasAuthorship W2019296957A5035229665 @default.
- W2019296957 hasAuthorship W2019296957A5042906478 @default.
- W2019296957 hasAuthorship W2019296957A5076440455 @default.
- W2019296957 hasBestOaLocation W20192969572 @default.
- W2019296957 hasConcept C104863432 @default.
- W2019296957 hasConcept C118552586 @default.
- W2019296957 hasConcept C126322002 @default.
- W2019296957 hasConcept C168563851 @default.
- W2019296957 hasConcept C1862650 @default.
- W2019296957 hasConcept C197934379 @default.
- W2019296957 hasConcept C2779457091 @default.
- W2019296957 hasConcept C2780192228 @default.
- W2019296957 hasConcept C2780665704 @default.
- W2019296957 hasConcept C2984752397 @default.
- W2019296957 hasConcept C512399662 @default.
- W2019296957 hasConcept C71924100 @default.
- W2019296957 hasConcept C84393581 @default.
- W2019296957 hasConceptScore W2019296957C104863432 @default.
- W2019296957 hasConceptScore W2019296957C118552586 @default.
- W2019296957 hasConceptScore W2019296957C126322002 @default.
- W2019296957 hasConceptScore W2019296957C168563851 @default.
- W2019296957 hasConceptScore W2019296957C1862650 @default.
- W2019296957 hasConceptScore W2019296957C197934379 @default.
- W2019296957 hasConceptScore W2019296957C2779457091 @default.
- W2019296957 hasConceptScore W2019296957C2780192228 @default.
- W2019296957 hasConceptScore W2019296957C2780665704 @default.
- W2019296957 hasConceptScore W2019296957C2984752397 @default.
- W2019296957 hasConceptScore W2019296957C512399662 @default.
- W2019296957 hasConceptScore W2019296957C71924100 @default.
- W2019296957 hasConceptScore W2019296957C84393581 @default.
- W2019296957 hasIssue "9" @default.
- W2019296957 hasLocation W20192969571 @default.
- W2019296957 hasLocation W20192969572 @default.
- W2019296957 hasLocation W20192969573 @default.
- W2019296957 hasLocation W20192969574 @default.
- W2019296957 hasOpenAccess W2019296957 @default.
- W2019296957 hasPrimaryLocation W20192969571 @default.
- W2019296957 hasRelatedWork W167801806 @default.
- W2019296957 hasRelatedWork W1984627805 @default.
- W2019296957 hasRelatedWork W2019296957 @default.